A negative correlation between mir‐210‐3p expression and CCL2 levels in human lung adenocarcinoma patients (Fig. 1H) incites further investigation of the role of miR210‐3p in CCL2 regulation in hypoxic tumors. The gene discussed is CCL2; the disease is lung adenocarcinoma.